Skip to content

Comparison of propofol and sevoflurane general anesthesia on intraoperative dreaming in patients undergoing hysteroscopy

Comparison of propofol and sevoflurane general anesthesia on intraoperative dreaming in patients undergoing hysteroscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058576
Enrollment
Unknown
Registered
2022-04-11
Start date
2022-03-25
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial polyp

Interventions

Group S:Sevoflurane inhalation was administered under anesthesia
Group P:Propofol was administered under intravenous anesthesia

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing hysteroscopy, including endometrial polypectomy, cervical contomy; 2. Aged from 20 to 40 years, BMI 18.5 to 24; 3. ASA I-II; 4. No contraindication certificate of general anesthesia; 5. Cognitive function is normal; 6. Informed consent was signed at the pre-anesthesia visit.

Exclusion criteria

Exclusion criteria: 1. The patient has hearing impairment; 2. Patients taking psychotropic drugs; 3. The patient has obvious psychological and neurological abnormalities; 4. Operation duration is longer than 60min; 5. Patients who could not receive follow-up and could not communicate in Mandarin within 24 h after surgery; 6. Declined to participate in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of dreaming;

Secondary

MeasureTime frame
The quality of dreams;Cervical atrophy, difficult to expand the palace;Nausea, vomiting;The difficulty of putting the laryngeal mask in;

Countries

China

Contacts

Public ContactWu Changyi

Peking University Third Hospital

iamwuchangyi@aliyun.com+86 13522028771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026